With a market cap of $9.3 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of messenger RNA (mRNA) therapeutics and vaccines. Known for its COVID-19 vaccine ...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some ...

It’s a much quieter week on the earnings front compared to last week, but we do still have some big names reporting including Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Coinbase (COIN ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor ...

The United States has long benefited from an enormous brain gain, with the most talented scientists and engineers around the ...

Learn more about whether Moderna, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

We've identified three large-cap value mutual funds that have given impressive annualized returns over 3-year and 5-year periods. These funds also hold a Zacks Mutual Fund Rank of #1 (Strong Buy ...

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...